Literature DB >> 9675466

Diagnosis and epidemiology of echovirus 22 infections.

P Joki-Korpela1, T Hyypiä.   

Abstract

To find out whether the appearance and pathogenicity of infections caused by echovirus 22 (EV22)--which has considerably different molecular characteristics from those of typical enteroviruses--exhibit extraordinary features, novel diagnostic approaches were applied. Staining of inoculated cell cultures with specific antibodies was followed by immunoperoxidase detection. Of fecal specimens from 140 children under 6 years of age, four were positive by the immunoperoxidase method. The nucleotide identity between these samples and additional EV22 isolates from Finland and the United States varied from 78% to 93% when studied by specific polymerase chain reaction, followed by sequence analysis of the amplicons. One-hundred ten single serum specimens collected from individuals in different age groups to find out the prevalence of EV22 antibodies were subjected to neutralization tests. Out of 21 neonates, 20 (95%) had EV22 antibodies, probably of maternal origin. Of 10 children aged 2-12 months, only two had neutralizing antibodies to EV22. The antibody levels increased rapidly by age, and among 30 adults tested, 29 (97%) were seropositive. A clear difference was observed with the occurrence of echovirus 30 (EV30) antibodies, which were less prevalent and appeared later in life. A review of previously published studies concerning the epidemiology of EV22 infections showed that gastroenteritis and respiratory infections are the most common symptoms observed in EV22 infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675466     DOI: 10.1086/514615

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 2.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

3.  Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.

Authors:  B M Westerhuis; K S M Benschop; G Koen; Y B Claassen; K Wagner; A Q Bakker; K C Wolthers; T Beaumont
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

4.  Human parechovirus in respiratory specimens from children in Kansas City, Missouri.

Authors:  Justin Sharp; Jeremiah Bell; Christopher J Harrison; W Allan Nix; M Steven Oberste; Rangaraj Selvarangan
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

5.  Detection of human picornaviruses by multiplex reverse transcription-PCR and liquid hybridization.

Authors:  Pia Jokela; Päivi Joki-Korpela; Marita Maaronen; Virpi Glumoff; Timo Hyypiä
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Diversity of human parechoviruses isolated from stool samples collected from Thai children with acute gastroenteritis.

Authors:  Ngan Thi Kim Pham; Quang Duy Trinh; Pattara Khamrin; Niwat Maneekarn; Hideaki Shimizu; Shoko Okitsu; Masashi Mizuguchi; Hiroshi Ushijima
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

7.  Detection of all known parechoviruses by real-time PCR.

Authors:  W Allan Nix; Kaija Maher; E Susanne Johansson; Bo Niklasson; A Michael Lindberg; Mark A Pallansch; M Steven Oberste
Journal:  J Clin Microbiol       Date:  2008-06-04       Impact factor: 5.948

8.  High prevalence of human Parechovirus (HPeV) genotypes in the Amsterdam region and identification of specific HPeV variants by direct genotyping of stool samples.

Authors:  K Benschop; X Thomas; C Serpenti; R Molenkamp; K Wolthers
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

9.  Isolation and characterization of novel human parechovirus from clinical samples.

Authors:  Kanako Watanabe; Masayasu Oie; Masaya Higuchi; Makoto Nishikawa; Masahiro Fujii
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Novel human parechovirus, Sri Lanka.

Authors:  Ngan Thi Kim Pham; Quang Duy Trinh; Sayaka Takanashi; Chandra Abeysekera; Asiri Abeygunawardene; Hideaki Shimizu; Pattara Khamrin; Shoko Okitsu; Masashi Mizuguchi; Hiroshi Ushijima
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.